OmniaBio
Kaytrina Anchelia is an experienced professional in business development within the biotechnology sector, currently serving as Director of Business Development at OmniaBio since September 2024. Prior to this role, Anchelia held the same position at iVexSol from May 2023 to August 2024 and was Associate Director of Business Development at Akron Biotech from January 2019 to May 2023, as well as Technical Account & Project Manager. Earlier experience includes Project Manager and Associate Scientist positions at Cytonics Corporation from April 2017 to December 2018. Kaytrina Anchelia earned a Bachelor of Science in Biology from the University of Miami in 2014.
This person is not in any teams
This person is not in any offices
OmniaBio
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.